Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Apr 22, 2026

Ducommun (DCO): Q1 2026 Earnings Preview Amid Record Backlog and Defense Strength

Key Takeaways

  • Analysts forecast Q1 2026 revenue of approximately $200 million, up roughly 3% from $194.1 million in Q1 2025.
  • Consensus EPS estimate stands at $0.72 to $0.82 per share, reflecting cautious growth amid seasonal trends, though Ducommun has consistently beaten estimates.
  • Record remaining performance obligations (RPO) of $1.106 billion at year-end 2025 provides strong revenue visibility, driven by military and space demand.
  • Gross margins expected to remain robust around 27%, building on Q4 2025's 27.7% record.
  • Investors watching for updates on defense ramps and commercial aerospace recovery signals.
  • Historical post-earnings stock moves average positive on beats, with recent quarters showing gains of 5-10%.

Earnings Context and Why It Matters

Ducommun (DCO), a key supplier of components and assemblies for aerospace, defense, and industrial sectors, is approaching its Q1 2026 earnings with solid momentum from a record-breaking 2025. Full-year revenue came in at $824.7 million, up 4.9%, even after a $107.3 million litigation charge affected net income. Adjusted EBITDA hit a record $135.6 million, or 16.4% of revenue, which underscores their strong margin discipline. In my view, this report is particularly important as it will offer visibility into defense production ramps aligned with U.S. Department of Defense priorities and any initial signs of relief from commercial aerospace destocking. With shares up notably year-to-date on backlog strength, investors are eager for confirmation of ongoing growth in this volatile sector.

Earnings Expectations

Wall Street's average call from five analysts points to Q1 2026 revenue of $199.8 million, marking modest growth both sequentially from Q4 2025's $215.8 million and year-over-year from Q1 2025's $194.1 million. The EPS consensus ranges from $0.72 (Zacks) to $0.82 (MarketBeat), a slight dip from Q1 2025's adjusted $0.83 but in line with typical seasonal patterns for the sector.

Ducommun has a strong track record, beating EPS estimates over the last eight quarters with average surprises of 15-20%—Q4 2025 saw $1.05 actual versus $0.91 expected, for instance. Key areas to monitor include RPO conversion, gross margins (27.7% in Q4), and adjusted EBITDA margins. Management didn't provide formal Q1 guidance after Q4, but they emphasized strength in missile programs through long-term agreements (LTAs) with RTX and Lockheed Martin, helping offset commercial challenges. I also checked DCO against industry peers using Tickeron’s AI Screener to gauge its relative positioning.

AI Screener

One tool I rely on regularly for digging deeper into stocks like DCO is Tickeron’s AI Screener. This AI-powered stock and ETF discovery platform lets me filter thousands of assets using customizable criteria like technical patterns, fundamentals, trends, volatility, and AI signals—think industry filters, market cap, indicators, price patterns, and performance metrics. It surfaces trade ideas, breakout candidates, and market opportunities far more efficiently than manual scans, streamlining my research process. If you're screening for similar setups in aerospace and defense, it's a solid addition to your toolkit.

Market Reaction and Investor Sentiment

As we head into Q1 earnings expected on May 5, 2026, sentiment toward DCO remains cautiously optimistic, supported by the $1.1 billion RPO and favorable defense trends. The stock has responded well to prior beats, including gains after Q4 2025 despite a minor revenue shortfall. Potential risks involve commercial aerospace delays and tariff impacts, though management views them as immaterial. Implied volatility indicates a possible 10-12% move post-earnings, which is standard for the sector.

Forward Outlook and Key Factors to Monitor

Post-Q1, the focus will shift to any full-year 2026 guidance, leveraging 2025's strong results. Management anticipates ramps in missile production and defense spending to boost military/space revenue, backed by LTAs and DoD priorities.

Progress in commercial aerospace will depend on Boeing's production increases and destocking normalization, which could pick up in H2 2026. One thing I'll be tracking closely is RPO evolution from $1.106 billion, book-to-bill ratios (1.3x in Q4), and margin progress toward the VISION 2027 goal of 18% adjusted EBITDA.

Additional drivers include growth in engineered products (23% of 2025 revenue, up from 15% in 2022) and tariff strategies like exemptions or pass-throughs. Broader tailwinds from steady defense budgets persist, while supply chain steadiness will affect efficiency. From what I see, these elements position DCO well for continued execution.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: DCO

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


DCO sees its Stochastic Oscillator climbs out of oversold territory

On September 14, 2026, the Stochastic Oscillator for DCO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In 40 of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DCO's RSI Oscillator exited the oversold zone, 9 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.

Following a +4.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCO advanced for three days, in 234 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

DCO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCO as a result. In 52 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for DCO turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 23 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 48%.

DCO moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DCO crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 38%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for DCO entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 12 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. DCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.636) is normal, around the industry mean (6.438). P/E Ratio (34.664) is within average values for comparable stocks, (59.605). DCO's Projected Growth (PEG Ratio) (10.790) is slightly higher than the industry average of (2.578). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.001) is also within normal values, averaging (18.155).

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.8B. The market cap for tickers in the group ranges from 4.49 to 2.01T. SPCX holds the highest valuation in this group at 2.01T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -1%. For the same Industry, the average monthly price growth was -14%, and the average quarterly price growth was -7%. ELMT experienced the highest price growth at 42%, while VWAV experienced the biggest fall at -44%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 199%. For the same stocks of the Industry, the average monthly volume growth was 173% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 69
Price Growth Rating: 66
SMR Rating: 77
Profit Risk Rating: 74
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
DCO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of aircraft components and equipment

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
600 Anton Boulevard
Phone
+1 657 335-3665
Employees
2130
Web
https://www.ducommun.com
Interact to see
Advertisement
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.